Phase 1 trial of the topical microbicide BufferGel: Safety results from four international sites

Journal of Acquired Immune Deficiency Syndromes

Volumn 26, Issue 1, 2001, Pages 21-27

  Van De Wijgert, Janneke ^a,j   Fullem, Andrew ^b,k   Kelly, Clifton ^c   Mehendale, Sanjay ^d   Rugpao, Sungwal ^e   Kumwenda, Newton ^f   Chirenje, Zvavahera ^a   Joshi, Smita ^d   Taha, Taha ^g   Padian, Nancy ^h   Bollinger, Robert ⁱ   Nelson, Kenrad ^g  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b FAMILY HEALTH INTERNATIONAL   (United States)

^c Fred Hutchinson Cancer Center and University of Washington   (United States)

^d NATIONAL AIDS RESEARCH INSTITUTE   (India)

^e CHIANG MAI UNIVERSITY   (Thailand)

^f Johns Hopkins Project   (Malawi)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j POPULATION COUNCIL   (United States)

^k Massachusetts Department of Health   (United States)

more..

Author keywords

Anti infective agents; HIV prevention; Phase I clinical trial; Vaginal spermicide

Indexed keywords

CARBOPOL 974P; SPERMICIDAL AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IRRITANT DERMATITIS; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; VAGINA FLORA; VAGINITIS;

EID: 0035144537     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200101010-00003     Document Type: Article

References (39)

1. Female-controlled methods to prevent sexual transmission of HIV
2. A dosing study of non-oxynol-9 and genital irritation
3. Comparison of spermicides on vulvar, vaginal, and cervical mucosa
4. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection
5. Safety study of non-oxynol-9 as a vaginal microbicide: Evidence of adverse effects
6. The rate at which human sperm are immobilized and killed by mild acidity
7. Carbopol resin references
8. Final report on the safety assessment of carbomers -934, -910, -934P, -940, -941, and -962
9. Comparative study of inactivation of herpes simplex virus types 1 and 2 by commonly used anti septic agents
10. Biology of Neisseria gonorrhoeae
11. Response of gonococcal clinical isolates to acidic conditions
12. Effect of pH on the motility and virulence of Treponema pallidum (Nichols) and Treponema paraluis cuniculi in vitro under anaerobic conditions
13. Characteristics of Haemophilus ducreyi in culture
14. Antibiosis between bacteria isolated from the vagina of women with and without signs of bacterial vaginosis
15. Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus
16. Acid sensitivity of cell-free and cell-associated HIV-1: Clinical implications
17. The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro
18. The safety and tolerability of BufferGel, a novel vaginal microbicide studied in U.S. women
19. Acceptability of a novel vaginal microbicide, BufferGel(tm), during a phase I safety trial among low-risk women in Rhode Island
20. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation
21. A placebo-controlled, double-blind prospective study in healthy female volunteers of Dextrin Sulphate gel
22. Colposcopic evaluation of a vaginal gel formulation of iota-Carrageenan
23. A phase I study of a novel potential intravaginal microbicide, PRO-2000, in healthy sexually active women
24. What is normal vaginal flora?
25. A longitudinal study of the vaginal flora over a menstrual cycle
26. Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women
27. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition
28. Is the lack of occurrence of bacterial vaginosis and vaginal candidosis explained by the presence of bacterial amines?
29. Microbial flora associated with Candida albicans vulvovaginitis
30. Treatment of bacterial vaginosis: A comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream
31. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV
32. Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women
33. Bacterial vaginosis